drugset / Trial / NCT05410223
Efficacy and Safety Study of Egg Yolk Antibody in Adjuvant Treatment of Helicobacter Pylori Infection
RandomizedParallel-groupDouble-blindTreatment
Summary
Helicobacter pylori is an important pathogenic factor for gastrointestinal diseases such as gastritis, peptic ulcer, gastric mucosa-associated lymphoid tissue lymphoma and gastric cancer.However, with the increasing use of antibiotics, antibiotic resistance of Helicobacter pylori continues to rise. In this study, we used egg yolk antibody combined with bismuth quadruple therapy to treat patients with Helicobacter pylori infection, and observed the eradication rate of Helicobacter pylori, the relief of clinical symptoms and the incidence of adverse reactions.
Timeline
- Start
- 2021-04-06
- Primary completion
- 2022-12-01
- Completion
- 2022-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bismuth Potassium Citrate | Unknown | — | — |
| Subject | Yolk antibody | Protein / enzyme biologic | — | — |
| Background | Amoxicillin | Other / unclassified | — | — |
| Background | Clarithromycin | Small molecule | — | — |
| Background | Doxycycline | Small molecule | — | — |
| Background | Furazolidone | Small molecule | — | — |
| Background | Ilaprazole | Small molecule | — | — |